No profile data available.
enVVeno Medical Corporation (NVNO) is a healthcare company in the targeted healthcare equipment industry, based in Irvine, United States, with about 33 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$19.47 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. Its market capitalization was $6.08 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency.
enVVeno Medical reported $0 in revenue for fiscal year 2025. In Q1 2026 revenue was $0.
$6.08 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Work Medical Technology Group LTD (WOK), CYduct Diagnostics, Inc. (CYDX), Autonomix Medical, Inc. (AMIX), IceCure Medical Ltd (ICCM).